Search

everythinglearnresearchcommunity

for

Search:↓

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

MPZL3 is crucial for seborrheic dermatitis development.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Finasteride and baicalin in phospholipid vesicles effectively promote hair growth and increase follicle count.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

New treatments focusing on immune pathways show promise for stubborn hair loss.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.